Updated Interim Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Updated Interim Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Updated Interim Analysis Today - Breaking & Trending Today

Ionis announces new donidalorsen data and presentations at the 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting

Published: February 21, 2023

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced additional positive interim data from a Phase 2 open-label extension (OLE) study of...

Source: prnewswire.com

Related Topics:

United StatesSan AntonioRichards GearyExchange CommissionAmerican Academy Of Allergy Asthma ImmunologyPrnewswire Ionis Pharmaceuticals IncIonis Pharmaceuticals IncIonis PharmaceuticalsAngioedema QualityAmerican AcademyAllergy AsthmaAnnual MeetingLabel Extension StudyHereditary AngioedemaUpdated Interim AnalysisDonidalorsen TreatmentDonidalorsen Taken EveryConjugated Antisense